Delivery Order SPE2DB25D3012-SPE2DB25FWWXR
Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for HUMIRA Pen 40 mg/0.8 mL, a biologic medication used to treat autoimmune conditions. The contract, valued at $2,265.90, was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order issued under a non-set-aside procurement, reflecting open competition. The place of performance is listed as AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,330.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. The contract, with an ultimate completion date of September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was made on a competitive basis with no...
- AmerisourceBergen Drug Corp received a competitive delivery order award from the Defense Logistics Agency (DLA) valued at $8,291.76 for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for immunological conditions. The contract is unclassified as a set-aside and carries a firm fixed-price structure with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters, where...
- The Defense Logistics Agency awarded a delivery order valued at $9,883.59 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered from...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL medication. This is a firm fixed-price delivery order valued at $33,364.14, with an ultimate completion date of July 22, 2025. The award carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a $1,510.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, an immunosuppressant medication used to treat autoimmune diseases. This firm fixed-price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a single-transaction purchase under a larger contract vehicle. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,356.75 on September 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic medication used to treat inflammatory conditions. This firm fixed-price delivery order, which represents no set-aside designation, is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a biologic medication used to treat inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,079.62 and is scheduled for completion by July 2, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $34,594.70 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on July 28, 2025, with a completion date of July 29, 2025. This non-competitive, firm fixed-price delivery order represents a fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. The product will be delivered to...